• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET XXL 360 6MM X 20CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET XXL 360 6MM X 20CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0036180620
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/14/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during the procedure subject coil was prematurely detached while advancing in the microcatheter.The subject coil was removed with the entire microcatheter, and procedure was completed successfully with another device.There were no clinical consequences to the patient reported as a result of this event.
 
Additional Manufacturer Narrative
Due to the automated manufacturing execution system (mes) there are controls in the manufacturing process to ensure the product met specifications upon release.The subject coil was not returned for analysis; therefore, physical as well as a functional testing could not be performed.The reported event is covered in the device direction for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the subject coil was not returned.Additional information provided by the customer indicated that continuous flush was not set up and maintained throughout the clinical procedure.In the case of this complaint, it is probable that lack of continuous flush contributed to the reported event.Per the dfu: in order to achieve optimal performance of the detachable coil system and to reduce the risk of thromboembolic complications, it is critical that a continuous infusion of appropriate flush solution be maintained between a) the femoral sheath and guiding catheter, b) the 2-tip microcatheter and guiding catheters, and c) the 2-tip microcatheter and stryker neurovascular guidewire and delivery wire.Continuous flush also reduces the potential for thrombus formation on, and crystallization of infusate around, the detachment zone of the detachable coil.An assignable cause of use error will be assigned to the as reported code main coil prematurely detached/separated during use, since there was a deviation from the supplied dfu that resulted in a different medical product response than intended by the manufacturer or expected by the user.
 
Event or Problem Description
It was reported that during the procedure subject coil was prematurely detached while advancing in the microcatheter.The subject coil was removed with the entire microcatheter, and procedure was completed successfully with another device.There were no clinical consequences to the patient reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET XXL 360 6MM X 20CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key19462523
Report Number3008881809-2024-00249
Device Sequence Number12744177
Product Code HCG
UDI-Device Identifier07613327466386
UDI-Public07613327466386
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K161429
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Distributor
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/09/2024
Device Catalogue NumberM0036180620
Device Lot Number23057583
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/15/2024
Supplement Date Received by Manufacturer06/19/2024
Initial Report FDA Received Date06/04/2024
Supplement Report FDA Received Date07/12/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/11/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
BISHOP MICROCATHETER (PIOLAX)
Patient Age82 YR
Patient SexFemale
-
-